Martin Ostrowski
Chief Tech/Sci/R&D Officer at Ryne Biotechnology, Inc.
Profile
Martin is a venture partner and general counsel at Saisei Ventures.
With over twenty years in the advanced regenerative medicine industry, his professional career has spanned academic research, to business development and commercialization activities, to prosecuting and litigating domestic and international intellectual property and estate building, to leadership roles in the biotech and pharma industries.
Martin previously practiced law at Sughrue Mion, PLLC, served as Director of Intellectual Property and Business Development at Cellscript, co-founded two biotech spin-outs in the advanced medicine sector, Vascugen and Dianomi Therapeutics, and is currently the Chief Technology Officer at Ryne Biotechnology.
Martin Ostrowski active positions
| Companies | Position | Start |
|---|---|---|
Saisei Ventures LLC
 Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 2022-12-31 |
Ryne Biotechnology, Inc.
 Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development. | Chief Tech/Sci/R&D Officer | 2022-02-28 |
Former positions of Martin Ostrowski
| Companies | Position | End |
|---|---|---|
Dianomi Therapeutics, Inc.
 Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Dianomi Therapeutics, Inc. engages in the development of Mineral Coated Microparticle (MCM) technology. It focuses on the improvement of drug molecules for targeting autoimmune diseases. The company was founded by Barry Kurokawa, William Murphy, Martin Ostrowski, and Anna Clements in 2017 and is headquartered in Madison, WI. | Founder | 2020-07-30 |
Vascugen, Inc.
 Vascugen, Inc. BiotechnologyHealth Technology Vascugen, Inc. provides biotechnology services. The company is headquartered in Madison, WI. | Founder | 2019-11-29 |
mRNA RiboTherapeutics, Inc.
 mRNA RiboTherapeutics, Inc. BiotechnologyHealth Technology mRNA RiboTherapeutics, Inc. provides products and technology for making and using ribonucleic acid for translation in cells for clinical research and therapeutics. It offers products for MRNA production in vitro transcription, post-transcriptional capping, co--transcriptional capping, post-transcriptional tailing, modified NTP in vitro transcription, mRNA decapping, and RNase inhibition. The company is headquartered in Madison, WI. | Director/Board Member | 2019-01-01 |
Training of Martin Ostrowski
| Case Western Reserve University School of Law | Graduate Degree |
| Case Western Reserve University School of Medicine | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
mRNA RiboTherapeutics, Inc.
mRNA RiboTherapeutics, Inc. BiotechnologyHealth Technology mRNA RiboTherapeutics, Inc. provides products and technology for making and using ribonucleic acid for translation in cells for clinical research and therapeutics. It offers products for MRNA production in vitro transcription, post-transcriptional capping, co--transcriptional capping, post-transcriptional tailing, modified NTP in vitro transcription, mRNA decapping, and RNase inhibition. The company is headquartered in Madison, WI. | Health Technology |
Dianomi Therapeutics, Inc.
Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Dianomi Therapeutics, Inc. engages in the development of Mineral Coated Microparticle (MCM) technology. It focuses on the improvement of drug molecules for targeting autoimmune diseases. The company was founded by Barry Kurokawa, William Murphy, Martin Ostrowski, and Anna Clements in 2017 and is headquartered in Madison, WI. | Health Technology |
Vascugen, Inc.
Vascugen, Inc. BiotechnologyHealth Technology Vascugen, Inc. provides biotechnology services. The company is headquartered in Madison, WI. | Health Technology |
Saisei Ventures LLC
Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Ryne Biotechnology, Inc.
Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development. | Health Technology |
- Stock Market
- Insiders
- Martin Ostrowski
